14.01.2021 07:00 | | Notice of Preliminary Results | RNS |
29.12.2020 07:00 | | TR-1: Notification of major holdings | RNS |
23.12.2020 09:00 | | Share Purchases by Directors | RNS |
22.12.2020 17:13 | | TR-1: Notification of major holdings | RNS |
22.12.2020 08:30 | | Admission of Placing | RNS |
21.12.2020 12:26 | | Results of Open Offer and General Meeting | RNS |
02.12.2020 07:10 | | New Grant of Options | RNS |
02.12.2020 07:00 | | Placing and Open Offer Announcement | RNS |
27.10.2020 07:00 | | Appointment of Chief Medical Officer | RNS |
09.09.2020 06:00 | | Research collaboration with Jazz Pharmaceuticals | RNS |
03.09.2020 14:00 | | TR-1: Notification of major holdings | RNS |
17.08.2020 13:05 | | Second Price Monitoring Extn | RNS |
17.08.2020 13:00 | | Price Monitoring Extension | RNS |
05.08.2020 06:00 | | Appointment of NED and changes to Board committees | RNS |
04.08.2020 06:37 | | Out licensing agreement with AstraZeneca | RNS |
20.07.2020 10:35 | | Result of General Meeting | RNS |
02.07.2020 13:05 | | Second Price Monitoring Extn | RNS |
02.07.2020 13:00 | | Price Monitoring Extension | RNS |
01.07.2020 11:30 | | Director/PDMR Shareholding | RNS |
30.06.2020 10:30 | | Holding(s) in Company | RNS |
30.06.2020 06:46 | | Share Option Scheme | RNS |
30.06.2020 06:02 | | Interim Results | RNS |
30.06.2020 06:00 | | Proposed financing of $30m and notice of GM | RNS |
15.06.2020 10:05 | | Second Price Monitoring Extn | RNS |
15.06.2020 10:00 | | Price Monitoring Extension | RNS |
20.05.2020 06:00 | | Change of Adviser | RNS |
18.05.2020 06:00 | | Appointment of Non-Executive Director | RNS |
06.05.2020 07:45 | | Holding(s) in Company | RNS |
05.05.2020 08:45 | | Holding(s) in Company | RNS |
04.05.2020 08:32 | | Form 8.3 - [REDX PHARMA PLC] | REDX PHARMA PLC |
01.05.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
01.05.2020 06:00 | | Offer Closed | RNS |
29.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
23.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
23.04.2020 10:32 | | Result of AGM and operational update | RNS |
21.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
20.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
17.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
15.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
14.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
09.04.2020 17:10 | | Redx Pharma | RNS |
09.04.2020 15:47 | | PUBLICATION OF OFFER DOCUMENT | RNS |
09.04.2020 12:58 | | Offer Update - Share Acquisitions | RNS |
07.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
06.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
03.04.2020 08:44 | | Form 8 (DD) - Redx Pharma PLC | RNS |
03.04.2020 08:27 | | Form 8.5 - RedX Pharma Plc | RNS |
03.04.2020 08:14 | | Holding(s) in Company | RNS |
03.04.2020 06:00 | | Form 8.3 - Redx Pharma plc | RNS |
02.04.2020 13:31 | | Offer Update - Share Acquisitions | RNS |
02.04.2020 11:27 | | Form 8.5 - RedX Pharma Plc | RNS |
02.04.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
02.04.2020 10:20 | | Holding(s) in Company | RNS |
02.04.2020 08:55 | | Form 8 (DD) - Redx Pharma PLC | RNS |
01.04.2020 11:13 | | Form 8.5 - Redx Pharma Plc | RNS |
01.04.2020 10:01 | | Form 8 (DD) - Redx Pharma PLC | RNS |
31.03.2020 06:00 | | Information regarding Company AGM | RNS |
30.03.2020 10:45 | | Form 8.5 (EPT/RI) | RNS |
30.03.2020 06:00 | | £5 million short term loan agreement | RNS |
27.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
27.03.2020 11:43 | | Form 8 (OPD) - Redx Pharma Plc | RNS |
26.03.2020 14:03 | | Form 8.3 - Redx Pharma plc | RNS |
26.03.2020 13:42 | | Form 8.3 - Redx Pharma plc | RNS |
26.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
25.03.2020 11:45 | | Holding(s) in Company | RNS |
25.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
24.03.2020 18:13 | | Form 8.3 - RedX Pharma PLC | RNS |
24.03.2020 11:33 | | Form 8.5 - RedX Pharma Plc | RNS |
24.03.2020 08:55 | | Form 8 (DD) | RNS |
23.03.2020 13:19 | | Holding(s) in Company | RNS |
23.03.2020 12:37 | | Form 8.5 - Redx Pharma Plc | RNS |
23.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
23.03.2020 10:42 | | Form 8 (DD) - Redx Pharma PLC | RNS |
20.03.2020 16:37 | | Form 8.3 - Redx Pharma plc | RNS |
20.03.2020 16:30 | | Form 8.3 - Redx Pharma | RNS |
20.03.2020 13:55 | | Holding(s) in Company | RNS |
19.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
18.03.2020 14:01 | | Form 8.3 - Redx Pharma PLC | RNS |
17.03.2020 14:54 | | Form 8.3 - Seneca Partners Limited | RNS |
17.03.2020 14:30 | | Form 8 (OPD) Redx Pharma plc | RNS |
17.03.2020 14:14 | | Form 8.3 - RedX Pharma plc | RNS |
17.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
16.03.2020 17:31 | | Holding(s) in Company | RNS |
16.03.2020 17:30 | | Holding(s) in Company | RNS |
16.03.2020 14:47 | | Form 8.3 - Redx Pharma plc | RNS |
16.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
16.03.2020 09:53 | | Form 8.3 - [REDX PHARMA PLC] | REDX PHARMA PLC |
13.03.2020 07:37 | | Holdings in Company | RNS |
13.03.2020 07:12 | | RECOMMENDED MANDATORY OFFER FOR REDX PHARMA PLC | RNS |
13.03.2020 07:00 | | Confirmation of Private Approach | RNS |
11.03.2020 07:00 | | Final Results for Year Ended 30 September 2019 | RNS |
09.03.2020 10:05 | | Holding(s) in Company | RNS |
02.03.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
02.03.2020 07:00 | | Re-release: Funding Update | RNS |
28.02.2020 18:29 | | Funding update | RNS |
28.02.2020 17:56 | | Termination of discussions with Yesod Bio-Sciences | RNS |
28.02.2020 16:57 | | Rule 2.8 Announcement | RNS |
27.02.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
26.02.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |
25.02.2020 11:45 | | Form 8.5 (EPT/RI) | RNS |